Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparinization in Intracranial Aneurysm Surgery
NCT05749393Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2023
- Primary completion
- Mar 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dextrose monohydrate + heparin sodium in intracranial aneurysm (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Size of the ischemic focus at 24 hours. Started Apr 2023; status: recruiting.
02
Drugs
dextrose monohydrate + heparin sodium
03
Conditions
intracranial aneurysm
Beyond the preview
Go deeper on NCT05749393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05749393.